Uncategorized

As Duchenne innovation booms, let’s ensure it becomes real progress

Published

on

At Sarepta Therapeutics, we’ve seen it all. Here are the questions I believe we should be asking to move forward in Duchenne muscular dystrophy.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version